Beyond Labels: Can Biomarkers and Treatable Traits Revolutionize Interstitial Lung Disease Care?

The classification of interstitial lung disease (ILD)s has traditionally relied on well-defined diagnostic labels, such as idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), and hypersensitivity pneumonitis (HP) [...]

Saved in:
Bibliographic Details
Published in:Biomedicines Vol. 13; no. 10; p. 2467
Main Authors: Amati, Francesco, Stainer, Anna, Aliberti, Stefano
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 10.10.2025
Subjects:
Biological markers
Biomarkers
Clinical trials
Diagnosis
Drug therapy
Health aspects
Lung diseases
Lung diseases, Interstitial
n/a
Patients
Physiological aspects
Precision medicine
Pulmonary fibrosis
Sarcoidosis
Italy
ISSN:2227-9059, 2227-9059
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The classification of interstitial lung disease (ILD)s has traditionally relied on well-defined diagnostic labels, such as idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), and hypersensitivity pneumonitis (HP) [...]
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines13102467